| Predicting drug susceptibility of non–small cell lung cancers based on genetic lesions ML Sos, K Michel, T Zander, J Weiss, P Frommolt, M Peifer, D Li, R Ullrich, ... The Journal of clinical investigation 119 (6), 1727-1740, 2009 | 325 | 2009 |
| Identifying genotype-dependent efficacy of single and combined PI3K-and MAPK-pathway inhibition in cancer ML Sos, S Fischer, R Ullrich, M Peifer, JM Heuckmann, M Koker, ... Proceedings of the National Academy of Sciences 106 (43), 18351-18356, 2009 | 298 | 2009 |
| Indication of horizontal DNA gene transfer by extracellular vesicles S Fischer, K Cornils, T Speiseder, A Badbaran, R Reimer, D Indenbirken, ... PLoS One 11 (9), e0163665, 2016 | 122 | 2016 |
| Metastatic prostate cancer: treatment options V Achard, PM Putora, A Omlin, T Zilli, S Fischer Oncology 100 (1), 48-59, 2022 | 81 | 2022 |
| European Association of Urology guidelines on testicular cancer: 2023 update A Patrikidou, W Cazzaniga, D Berney, J Boormans, I de Angst, D Di Nardo, ... European Urology 84 (3), 289-301, 2023 | 65 | 2023 |
| Outcome of men with relapse after adjuvant carboplatin for clinical stage I seminoma S Fischer, T Tandstad, M Wheater, E Porfiri, A Fléchon, J Aparicio, ... Journal of Clinical Oncology 35 (2), 194-200, 2017 | 56 | 2017 |
| Anti-PD-1 therapy leads to near-complete remission in a patient with metastatic basal cell carcinoma S Fischer, OH Ali, W Jochum, T Kluckert, L Flatz, M Siano Oncology Research and Treatment 41 (6), 391-394, 2018 | 50 | 2018 |
| Sequence of treatment in locally advanced and metastatic renal cell carcinoma S Fischer, S Gillessen, C Rothermundt Translational andrology and urology 4 (3), 310, 2015 | 30 | 2015 |
| Analysis of compound synergy in high-throughput cellular screens by population-based lifetime modeling M Peifer, J Weiss, ML Sos, M Koker, S Heynck, C Netzer, S Fischer, ... PloS one 5 (1), e8919, 2010 | 30 | 2010 |
| Outcome of men with relapses after adjuvant bleomycin, etoposide, and cisplatin for clinical stage I nonseminoma S Fischer, T Tandstad, G Cohn-Cedermark, C Thibault, B Vincenzi, ... Journal of Clinical Oncology 38 (12), 1322-1331, 2020 | 26 | 2020 |
| First-in-human phase I study of MP0250, a first-in-class DARPin drug candidate targeting VEGF and HGF, in patients with advanced solid tumors RD Baird, C Linossi, M Middleton, S Lord, A Harris, J Rodón, C Zitt, ... Journal of Clinical Oncology 39 (2), 145-154, 2021 | 25 | 2021 |
| EAU guidelines on testicular cancer 2020 MP Laguna, P Albers, F Algaba, C Bokemeyer, JL Boormans, S Fischer, ... European association of urology guidelines, 2020 | 22 | 2020 |
| Impact of COVID-19 pandemic on treatment patterns in metastatic clear cell renal cell carcinoma S Aeppli, EI Eboulet, T Eisen, B Escudier, S Fischer, J Larkin, ... ESMO open 5, e000852, 2020 | 21 | 2020 |
| European Association of Urology Guidelines MP Laguna, P Albers, F Algaba, C Bokemeyer, BL Boormans, S Fischer, ... Edition. Arnhem: European Association of Urology Guidelines Office, 2020 | 18 | 2020 |
| Xaluritamig, a STEAP1× CD3 XmAb 2+ 1 immune therapy for metastatic castration-resistant prostate cancer: results from dose exploration in a first-in-human study WK Kelly, DC Danila, CC Lin, JL Lee, N Matsubara, PJ Ward, ... Cancer Discovery 14 (1), 76-89, 2024 | 15 | 2024 |
| EAU guidelines MP Laguna, P Albers, F Algaba, C Bokemeyer, J Boormans, S Fischer, ... EAU Annual Congress Amsterdam, 2020 | 15 | 2020 |
| Influence of abiraterone and enzalutamide on body composition in patients with metastatic castration resistant prostate cancer S Fischer, S Clements, A McWilliam, A Green, T Descamps, C Oing, ... Cancer Treatment and Research Communications 25, 100256, 2020 | 14 | 2020 |
| Testicular cancer MP Laguna, P Albers, F Algaba, C Bokemeyer, JL Boormans, S Fischer, ... EAU Annual Congress Amsterdam, 2020 | 13 | 2020 |
| Humoral and cellular responses to mRNA-based COVID-19 booster vaccinations in patients with solid neoplasms under active treatment E Su, S Fischer, R Demmer-Steingruber, S Nigg, S Güsewell, WC Albrich, ... ESMO open 7 (5), 100587, 2022 | 11 | 2022 |
| The value of tumour markers in the detection of relapse—lessons learned from the Swiss Austrian German Testicular Cancer Cohort Study S Fischer, C Rothermundt, O Stalder, A Terbuch, T Hermanns, D Zihler, ... European urology open science 50, 57-60, 2023 | 9 | 2023 |
